| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pulse Biosciences, Inc. (PLSE) has 8 insiders with recent SEC Form 4 filings, including 21 buys and 0 sells. PLSE is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 47.55M | $1.13B | - | |
| Other | 100.0K | $2.38M | - | |
| Other | 55.0K | $1.31M | - | |
| Other | 43.3K | $1.03M | - | |
| Dir | 30.0K | $714.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2020 | Zanganeh Maky84 | Director | Buy | 1,193 | $10.70 | $12,767.13 | +1.1% | |
| Jun 17, 2020 | Zanganeh Maky84 | Director | Buy | 7,950 | $7.01 | $55,729.50 | +8.1% | |
| May 11, 2018 | Duggan Robert W76 | Director, 10% Owner | Buy | 21,353 | $23.16 | $494,535.48 | +0.4% | |
| Dec 13, 2017 | Zanganeh Maky84 | Director | Buy | 1,100 | $23.98 | $26,378.00 | +1.2% | |
| Dec 13, 2017 | Duggan Robert W76 | Director, 10% Owner | Buy | 20,556 | $22.44 | $461,276.64 | +0.4% | |
| Dec 12, 2017 | Zanganeh Maky84 | Director | Buy | 4,000 | $23.07 | $92,268.00 | +2.2% | |
| Oct 19, 2017 | Duggan Robert W76 | 10% Owner | Buy | 22,901 | $22.79 | $521,867.99 | +0.4% | |
| Sep 24, 2017 | Duggan Robert W76 | 10% Owner | Buy | 2,000,000 | $15.02 | $30,040,000.00 | +52.7% | |
| Sep 18, 2017 | Zanganeh Maky84 | Director | Buy | 29,775 | $13.36 | $397,669.91 | +3.2% | |
| Sep 18, 2017 | Duggan Robert W76 | 10% Owner | Buy | 409,918 | $14.36 | $5,885,102.81 | +1.3% |